期刊文献+

集束化护理干预对慢性粒细胞白血病患者心理状态及生活质量的影响 被引量:5

Effects of cluster nursing intervention on psychological status and quality of life of patients with chronic myelogenous leukemia
下载PDF
导出
摘要 目的探讨集束化护理干预对慢性粒细胞白血病患者心理状态及生活质量的影响。方法将96例慢性粒细胞白血病患者采用随机数字表法分为观察组和对照组,每组48例。对照组给予常规护理,观察组在常规护理基础上联合集束化护理干预。于干预前后采用生存质量问卷评价患者的生存质量,采用焦虑自评量表及抑郁自评量表评定患者的焦虑、抑郁情绪。结果干预后两组生存质量问卷各因子评分均显著高于干预前(P〈0.05或0.01),观察组较对照组升高更显著(P〈0.01);两组焦虑自评量表及抑郁自评量表评分均显著低于干预前(P〈0.01),观察组较对照组下降更显著(P〈0.01)。结论集束化护理可明显提高慢性粒细胞白血病患者的生存质量,改善患者焦虑、抑郁情绪。 Objective To explore the effects of cluster nursing intervention on the psychological status and quality of life of patients with chronic myelogenous leukemia (CML). Methods Ninety-six CML patients were divided into the observation and control group of 48 ones each according to random number table. Control group received routine nursing and the observation was plus cluster nursing intervention on the hasis of routine nursing. Before and after intervention qualities of life were assessed with the Quality of Life Core Questionnaire (QLQ) as well as anxious and depressive emotions with the Self-rating Anxiety Scale (SAS) and Self-rating Depression Scale (SDS). Results All factors scores of the QLQ of both groups were significantly higher after intervention compared with pre-intervention (P 〈0.05 or 0.01), so were those in observation than in control group (P〈0. 01) ; the SAS and SDS scores of both groups were significantly lower after intervention compared with pre-intervention (P〈0.01), so were those in observation than in control group (P〈0.01). Conclusion Cluster nursing could notably boost the quality of life of patients with CML and improve anxious and depressive emotions.
出处 《临床心身疾病杂志》 CAS 2017年第2期75-77,共3页 Journal of Clinical Psychosomatic Diseases
基金 河南省科技攻关计划项目(编号132102310413)
关键词 集束化护理干预 慢性粒细胞白血病 生存质量问卷 焦虑 抑郁 焦虑自评量表 抑郁 Cluster nursing intervention CML QLQ anxiety depression SAS SDS
  • 相关文献

参考文献9

二级参考文献117

  • 1卢兴国.四片联检模式在血液形态学诊断中的应用[J].临床检验杂志(电子版),2014,3(3):641-664. 被引量:3
  • 2陈玉华,张日,仇红霞,单耀娟,吴绣文.慢性粒细胞白血病患者健康教育的实施[J].南方护理学报,2005,12(8):72-73. 被引量:4
  • 3干定云,陈燕.慢性粒细胞白血病分子靶向治疗的新进展[J].临床血液学杂志,2006,19(3):190-192. 被引量:20
  • 4肖志坚,钱林生.慢性粒细胞白血病的治疗进展[J].继续医学教育,2006,20(4):80-85. 被引量:7
  • 5陆再英,钟南山.内科学.7版.北京:人民卫生出版社,2008,1:267-294.
  • 6Hughes T, Saglio G, Branford S, et al. Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase [J] . J Clin Oncol, 2009, 27: 4204-4210.
  • 7Muller M C, Cortes J E, Kim D W, et al. Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations[J].Blood, 2009, 114: 4944-4953.
  • 8Oehler V G, Yeung K Y, Choi Y E, et al. The derivation of diagnostic markers of chronic myeloid leukemia progression from mieroarray data [J] . Blood, 2009, 114: 3292-3298.
  • 9Radich J P, Dai H, Mao M, et al. Gene expression changes associated with progression and response in chronic myeloid leukemia [J] . Proc Natl AcadSciUSA, 2006, 103: 2794-2799.
  • 10White D L, Dang P, Engler J, et al. Functional activity of the OCT-1 protein is predictive of long-term outcome in patients with chronic-phase chronic myeloid leukemia treated with imatinib [J] . J Clin Oncol, 2010, 28:2761-2767.

共引文献155

同被引文献36

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部